Tsang J - Search Results

1

The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver Transplants.

Li BCW, Chiu J, Shing K, Kwok GGW, Tang V, Leung R, Ma KW, She WH, Tsang J, Chan A, Cheung TT, Lo CM, Yau T. Li BCW, et al. Among authors: tsang j. Adv Ther. 2021 Jul;38(7):3900-3910. doi: 10.1007/s12325-021-01800-z. Epub 2021 Jun 1. Adv Ther. 2021. PMID: 34061324

2

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.

Wong JSL, Kwok GGW, Tang V, Li BCW, Leung R, Chiu J, Ma KW, She WH, Tsang J, Lo CM, Cheung TT, Yau T. Wong JSL, et al. Among authors: tsang j. J Immunother Cancer. 2021 Feb;9(2):e001945. doi: 10.1136/jitc-2020-001945. J Immunother Cancer. 2021. PMID: 33563773 Free PMC article.

3

Nivolumab + Ipilimumab for patients with hepatocellular carcinoma previously treated with Sorafenib.

Tsang J, Wong JSL, Kwok GGW, Li BCW, Leung R, Chiu J, Cheung TT, Yau T. Tsang J, et al. Expert Rev Gastroenterol Hepatol. 2021 Jun;15(6):589-598. doi: 10.1080/17474124.2021.1899808. Epub 2021 Mar 19. Expert Rev Gastroenterol Hepatol. 2021. PMID: 33666530 Review.

4

The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong-A Territory-Wide Cohort Study.

Wong JS, Dong Y, Tang V, Leung T, Yeung CSY, Tai A, Law A, Shum T, Kwok GG, Li BC, Leung R, Chiu J, Ma KW, She WH, Tsang J, Cheung TT, Yau T. Wong JS, et al. Among authors: tsang j. Cancers (Basel). 2021 Apr 21;13(9):2002. doi: 10.3390/cancers13092002. Cancers (Basel). 2021. PMID: 33919277 Free PMC article.

5

[No title available]

[No authors listed] [No authors listed] PMID: 34039694

6

Neoadjuvant Therapy with Concurrent Docetaxel, Epirubicin, and Cyclophosphamide (TEC) in High-Risk HER2-Negative Breast Cancers.

Li B, Yau T, Leung R, Kwok G, Tsang J, Cheung P, Wong TT, Suen D, Kwong A, Chiu JW. Li B, et al. Among authors: tsang j. Adv Ther. 2021 Dec;38(12):5752-5762. doi: 10.1007/s12325-021-01933-1. Epub 2021 Oct 26. Adv Ther. 2021. PMID: 34699004

7

Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study.

Wong CY, Leung R, Kwok GW, Tsang J, Li B, Yau T, Chiu J. Wong CY, et al. Among authors: tsang j. Postgrad Med J. 2022 Sep 1;98(1163):666-669. doi: 10.1136/postgradmedj-2021-140319. Postgrad Med J. 2022. PMID: 37062975

8

Robotic endovascular surgery.

Au S, Ko K, Tsang J, Chan YC. Au S, et al. Among authors: tsang j. Asian Cardiovasc Thorac Ann. 2014 Jan;22(1):110-4. doi: 10.1177/0218492313484736. Epub 2013 Oct 9. Asian Cardiovasc Thorac Ann. 2014. PMID: 24585662 Review.

9

Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model.

Bohannan Z, Pudupakam RS, Koo J, Horwitz H, Tsang J, Polley A, Han EJ, Fernandez E, Park S, Swartzfager D, Qi NSX, Tu C, Rankin WV, Thamm DH, Lee HR, Lim S. Bohannan Z, et al. Among authors: tsang j. Vet Comp Oncol. 2021 Mar;19(1):160-171. doi: 10.1111/vco.12656. Epub 2020 Oct 20. Vet Comp Oncol. 2021. PMID: 33025640 Free PMC article.

10

Predicting Dynamic Clinical Outcomes of the Chemotherapy for Canine Lymphoma Patients Using a Machine Learning Model.

Koo J, Choi K, Lee P, Polley A, Pudupakam RS, Tsang J, Fernandez E, Han EJ, Park S, Swartzfager D, Qi NSX, Jung M, Ocnean M, Kim HU, Lim S. Koo J, et al. Among authors: tsang j. Vet Sci. 2021 Dec 2;8(12):301. doi: 10.3390/vetsci8120301. Vet Sci. 2021. PMID: 34941828 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

817 results

Search Page

Filters